Abstract
Back pain is one of the most common complaints which brings patients to physician. Spine is one of the most common site for metastasis. The most common primary tumor in patients with metastasis are breast, lung, prostate and kidney.
This study aimed to evaluate patients profile for low backache in different types of malignancy.
Material and Methods: Total 50 patients of histopathologically proven different malignancy were retrospectively analysed for low backache during 2014 to 2016. Cases included were both metastatic bone disease in vertebrae, pelvic bone, proximal femur and primary tumors of spine.
Results: 46% of the patients were in age range of 50-69 years followed by 40% patients in age range of 30-49 years. Incidence of male were 18(36%) patients and female were 32(64%). 35(70%) patients were not addicted,9(18%) were addicted to tobacco alone,4(8%) patients were addicted to smoking alone, various others are addicted in combination. 47(94%) were metastatic bone disease, 3(6%) patients were primary wings sarcoma of spine. Majority of the patients were of breast cancer 20(40%), gynaecological cancer 8(16%), multiple myeloma and head and neck cancer each 6(12%) patients. Prostate cancer 4(8%), lung cancer 2(4%), renal cell cancer 1(2%) patient. Bony metastasis most common site were vertebra 16(32%), pelvis 12(24%), proximal femur 4(8%) cases. In combination group vertebra with pelvis 12(24%), vertebra with proximal femur 3(6%), proximal femur with pelvis 2(4%).
Bony metastasis in 19(38%) patients cases was associated with spinal mas, In 11(22%) patients mass was pressing spinal nerve roots, in 8(16%) patients causing compression of spinal cord. 7(14%) patients had pathological fracture.
Conclusion: pain caused by spinal metastasis is typically persistent and progressive not relieved by rest.Metastases may present as mechanical pain, radicular pain or weakness, or with myelopathy. Management of back pain in metastatic bone metastasis involve combination of pain based on specific patients, prognosis, neurological status, age, primary histopathology.
Keywords: Backache, metastatic bone disease, spine, vertebra.
References
1. Moore, J.E. (2010). Chronic low back pain and psychosocial issues. Phys Med RehabilClin NAm, Vol. 21, pp.801-15.
2. Henschke, N., Maher, C.G., Refshauge, K.M., Herbert, R.D., Cumming, R.G., Bleasel, J.,York, J., Das, A. &McAuley, J.H. (2009). Prevalence of and screening for seriousspinal pathology in patients presenting to primary care settings with acute low back pain. Arthritis Rheum, Vol. 60, pp.3072-80
3. Dagenais, S., Tricco, A.C. & Haldeman, S. (2010). Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines. Spine J, Vol. 10, pp.514-29.
4. Guillevin, R., Vallee, J.N., Lafitte, F., Menuel, C., Duverneuil, N.M. &Chiras, J. (2007). Spine metastasis imaging: review of the literature. J Neuroradiol, Vol. 34, pp.311-21
5. Sciubba, D.M., Nguyen, T. & Gokaslan, Z.L. (2009). Solitary vertebral metastasis. Orthop Clin North Am, Vol. 40, pp.145-54, viii.
6. Chamberlain, M.C. &Kormanik, P.A. (1999). Epidural spinal cord compression: a single institution's retrospective experi-ence. Neuro Oncol, Vol. 1, pp.120-3.
7. Bach, F., Larsen, B.H., Rohde, K., Borgesen, S.E., Gjerris, F., Boge-Rasmussen, T., Agerlin, N.,Rasmusson, B., Stjernholm, P. & Sorensen, P.S. (1990). Metastatic spinal cordcompression. Occurrence, symptoms, clinical presentations and prognosis in98 patients with spinal cord compression. Acta Neurochir (Wien), Vol. 107, pp.37-43
8. Cole, J.S. &Patchell, R.A. (2008). Meta-static epidural spinal cord compression. Lancet Neurol,Vol. 7, pp.459-66
9. Smith, H.S. (2011). Painful osseous metastases. Pain Physician, Vol. 14, pp.E373-403.
10. Shaw, B., Mansfield, F.L. & Borges, L. (1989). One-stage posterolateral decompr-ession andstabilization for primary and metastatic vertebral tumors in the thoracic andlumbar spine. J Neurosurg, Vol. 70, pp.405-10
11. Sundaresan, N., Sachdev, V.P., Holland, J.F., Moore, F., Sung, M., Paciucci, P.A., Wu, L.T.,Kelligher, K. & Hough, L. (1995). Surgical treatment of spinal cord compressionfrom epidural metastasis. J ClinOncol, Vol. 13, pp.2330-5.
12. Ratanatharathorn, V., Powers, W.E., Moss, W.T. & Perez, C.A. (1999). Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys, Vol. 44, pp.1-18.
13. Bilsky, M.H., Boland, P., Lis, E., Raizer, J.J. & Healey, J.H. (2000). Single-stage posterolateral transpedicle approach for spondylectomy, epidural decompression, and circumferential fusion of spinal metastases. Spine (Phila Pa 1976), Vol. 25, pp.2240-9,discussion 250
14. Byrne, T.N. (1992). Spinal cord compression from epidural metastases. N Engl J Med, Vol.327, pp.614-9
15. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 1978;3:40–51
16. Black P. Spinal metastasis: current status and recommended guidelines for manage-ment. Neurosurgery 1979; 5:726–746.
17. Alarmo EL, Kallioniemi A. Bone morphogenetic proteins in breast cancer - dual role in tumourigenesis? Endocr Relat Cancer. 2010 Mar 24.
18. Doot RK, Muzi M, Peterson LM, Schubert EK, Gralow JR, Specht JM, et al. Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases. J Nucl Med. 2010 Apr. 51(4):521-7.
19. Hung JJ, Jeng WJ, Hsu WH, Wu KJ, Chou TY, Hsieh CC, et al. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax. 2010 Mar. 65(3):241-5.
20. Edwards J. Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer. Expert OpinInvestig Drugs. 2010 Apr 5.
21. Brihaye J, Ectors P, Lemort M, Van Houtte P. The management of spinal epidural metastases. Adv Tech Stand Neuro surg 1988; 16:121–176.
DOI: https://dx.doi.org/10.18535/jmscr/v5i5.150
